skip to main content
Idioma:
Resultados 1 2 3 4 next page
Refinado por: assunto: Hiv remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Primary Antiretroviral drug resistance among HIV type 1-infected individuals in Brazil
Primary Antiretroviral drug resistance among HIV type 1-infected individuals in Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary Antiretroviral drug resistance among HIV type 1-infected individuals in Brazil

Eduardo Sprinz Eduardo M Netto; Maria Patelli J. S Lima; Juvênao J. D Furtado; Margareth da Eira; Roberto Zajdenverg; José V Madruga; David S Lewi; Alcyone Artioli Machado; Rogerio de Jesus Pedro; Marcelo A Soares

AIDS Research and Human Retroviruses New York v. 25, n. 9, p. 961-967, 2009

New York 2009

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1812190 estantes deslizantes )(Acessar)

2
Primary Antiretroviral drug resistance among HIV type 1-infected individuals in Brazil
Primary Antiretroviral drug resistance among HIV type 1-infected individuals in Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary Antiretroviral drug resistance among HIV type 1-infected individuals in Brazil

Eduardo Sprinz Eduardo M Netto; Maria Patelli J. S Lima; Juvênao J. D Furtado; Margareth da Eira; Roberto Zajdenverg; José V Madruga; David S Lewi; Alcyone Artioli Machado; Rogerio de Jesus Pedro; Marcelo A Soares

AIDS Research and Human Retroviruses New York v. 25, n. 9, p. 961-967, 2009

New York 2009

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1812190 estantes deslizantes )(Acessar)

3
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection the PrEP Brasil demonstration project
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection the PrEP Brasil demonstration project
Material Type:
Artigo 		Adicionar ao Meu Espaço

High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection the PrEP Brasil demonstration project

Brenda Hoagland Ronaldo I Moreira; Raquel B De Boni; Esper G Kallas; José Valdez Madruga; Ricardo Vasconcelos; Silvia Goulart; Thiago S Torres; Luana M. S Marins; Peter L Anderson; Paula M Luz; Iuri da Costa Leite; Albert Y Liu; Valdilea G Veloso; Beatriz Grinsztejn

Journal of the International AIDS Society London v. 20, 14 p., ID 21472, 2017

London 2017

Localização: FM - Fac. Medicina    (BCSEP 265 2017 )(Acessar)

4
Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil
Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil

Brenda Hoagland Raquel B De Boni; Ronaldo I Moreira; José Valdez Madruga; Esper G Kallas; Silvia Pereira Goulart; Natalia Cerqueira; Thiago S Torres; Paula M Luz; Nilo Martinez Fernandes; Albert Y Liu; Beatriz Grinsztejn; Valdilea G Veloso

AIDS and Behavior New York v. 21, n. 9, p. 1278-1287, 2017

New York 2017

Acesso online. A biblioteca também possui exemplares impressos.

5
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Cahn, Pedro, Dr ; Pozniak, Anton L, MD ; Mingrone, Horacio, MD ; Shuldyakov, Andrey, MD ; Brites, Carlos, MD ; Andrade-Villanueva, Jaime F, MD ; Richmond, Gary, MD ; Buendia, Carlos Beltran, MD ; Fourie, Jan, MD ; Ramgopal, Moti, MD ; Hagins, Debbie, MD ; Felizarta, Franco, MD ; Madruga, Jose, MD ; Reuter, Tania, MD ; Newman, Tamara, MD ; Small, Catherine B, MD ; Lombaard, John, MD ; Grinsztejn, Beatriz, MD ; Dorey, David, MMath ; Underwood, Mark, PhD ; Griffith, Sandy, PharmD ; Min, Sherene, MD

The Lancet (British edition), 2013-08, Vol.382 (9893), p.700-708 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Mills, Anthony, MD ; Arribas, Jose R, MD ; Andrade-Villanueva, Jaime, Prof ; DiPerri, Giovanni, MD ; Van Lunzen, Jan, Prof ; Koenig, Ellen, MD ; Elion, Richard, MD ; Cavassini, Matthias, MD ; Madruga, Jose Valdez, MD ; Brunetta, Jason, MD ; Shamblaw, David, MD ; DeJesus, Edwin, MD ; Orkin, Chloe, MBBch ; Wohl, David A, MD ; Brar, Indira, MD ; Stephens, Jeffrey L, MD ; Girard, Pierre-Marie, Prof ; Huhn, Gregory, MD ; Plummer, Andrew, BS ; Liu, Ya-Pei, PhD ; Cheng, Andrew K, MD ; McCallister, Scott, Dr

The Lancet infectious diseases, 2016-01, Vol.16 (1), p.43-52 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Lennox, Jeffrey L, Prof ; DeJesus, Edwin, MD ; Lazzarin, Adriano, Prof ; Pollard, Richard B, Prof ; Madruga, Jose Valdez Ramalho, MD ; Berger, Daniel S, MD ; Zhao, Jing, PhD ; Xu, Xia, PhD ; Williams-Diaz, Angela, BS ; Rodgers, Anthony J, MS ; Barnard, Richard JO, PhD ; Miller, Michael D, PhD ; DiNubile, Mark J, MD ; Nguyen, Bach-Yen, MD ; Leavitt, Randi, MD ; Sklar, Peter, Dr

The Lancet (British edition), 2009-09, Vol.374 (9692), p.796-806 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

KATLAMA, Christine ; HAUBRICH, Richard ; WOODFALL, Brian ; DE SMEDT, Goedele ; LALEZARI, Jacob ; LAZZARIN, Adriano ; MADRUGA, José V ; MOLINA, Jean-Michel ; SCHECHTER, Mauro ; PEETERS, Monika ; PICCHIO, Gaston ; VINGERHOETS, Johan

AIDS (London), 2009-11, Vol.23 (17), p.2289-2300 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
9
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Landovitz, Raphael J ; Donnell, Deborah ; Clement, Meredith E ; Hanscom, Brett ; Cottle, Leslie ; Coelho, Lara ; Cabello, Robinson ; Chariyalertsak, Suwat ; Dunne, Eileen F ; Frank, Ian ; Gallardo-Cartagena, Jorge A ; Gaur, Aditya H ; Gonzales, Pedro ; Tran, Ha V ; Hinojosa, Juan C ; Kallas, Esper G ; Kelley, Colleen F ; Losso, Marcelo H ; Madruga, J. Valdez ; Middelkoop, Keren ; Phanuphak, Nittaya ; Santos, Breno ; Sued, Omar ; Valencia Huamaní, Javier ; Overton, Edgar T ; Swaminathan, Shobha ; del Rio, Carlos ; Gulick, Roy M ; Richardson, Paul ; Sullivan, Philip ; Piwowar-Manning, Estelle ; Marzinke, Mark ; Hendrix, Craig ; Li, Maoji ; Wang, Zhe ; Marrazzo, Jeanne ; Daar, Eric ; Asmelash, Aida ; Brown, Todd T ; Anderson, Peter ; Eshleman, Susan H ; Bryan, Marcus ; Blanchette, Cheryl ; Lucas, Jonathan ; Psaros, Christina ; Safren, Steven ; Sugarman, Jeremy ; Scott, Hyman ; Eron, Joseph J ; Fields, Sheldon D ; Sista, Nirupama D ; Gomez-Feliciano, Kailazarid ; Jennings, Andrea ; Kofron, Ryan M ; Holtz, Timothy H ; Shin, Katherine ; Rooney, James F ; Smith, Kimberly Y ; Spreen, William ; Margolis, David ; Rinehart, Alex ; Adeyeye, Adeola ; Cohen, Myron S ; McCauley, Marybeth ; Grinsztejn, Beatriz

The New England journal of medicine, 2021-08, Vol.385 (7), p.595-608 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

Madruga, José Valdez, Dr ; Cahn, Pedro, MD ; Grinsztejn, Beatriz, MD ; Haubrich, Richard, Prof ; Lalezari, Jacob, MD ; Mills, Anthony, MD ; Pialoux, Gilles, Prof ; Wilkin, Timothy, MD ; Peeters, Monika, MSc ; Vingerhoets, Johan, PhD ; de Smedt, Goedele, MD ; Leopold, Lorant, MD ; Trefiglio, Roberta, PharmD ; Woodfall, Brian, MD

The Lancet (British edition), 2007-07, Vol.370 (9581), p.29-38 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (32)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2009  (5)
  2. 2009Até2012  (10)
  3. 2013Até2016  (4)
  4. 2017Até2020  (9)
  5. Após 2020  (6)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Madruga, J
  2. Furtado, J
  3. Eira, M
  4. Lewi, D
  5. Grinsztejn, B

Neste Assunto:

  1. Hiv
  2. Hiv
  3. Science & Technology
  4. Human Immunodeficiency Virus
  5. Life Sciences & Biomedicine

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.